Adial Pharmaceuticals, Inc. (ADIL)
6.65
-0.47
(-6.60%)
USD |
NASDAQ |
Sep 08, 16:00
6.65
0.00 (0.00%)
Pre-Market: 08:35
Adial Pharmaceuticals Market Cap : 17.46M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 17.46M |
| September 04, 2026 | 18.70M |
| September 03, 2026 | 17.49M |
| September 02, 2026 | 16.60M |
| September 01, 2026 | 15.62M |
| August 31, 2026 | 15.10M |
| August 28, 2026 | 14.70M |
| August 27, 2026 | 14.94M |
| August 26, 2026 | 15.60M |
| August 25, 2026 | 15.28M |
| August 24, 2026 | 14.18M |
| August 21, 2026 | 16.32M |
| August 20, 2026 | 15.49M |
| August 19, 2026 | 15.11M |
| August 18, 2026 | 14.31M |
| August 17, 2026 | 13.10M |
| August 14, 2026 | 10.45M |
| August 13, 2026 | 11.53M |
| August 12, 2026 | 11.32M |
| August 11, 2026 | 6.505M |
| August 10, 2026 | 6.354M |
| August 07, 2026 | 6.007M |
| August 06, 2026 | 7.244M |
| August 05, 2026 | 6.112M |
| August 04, 2026 | 5.735M |
| Date | Value |
|---|---|
| August 03, 2026 | 5.494M |
| July 31, 2026 | 5.041M |
| July 30, 2026 | 4.965M |
| July 29, 2026 | 4.754M |
| July 28, 2026 | 4.452M |
| July 27, 2026 | 4.241M |
| July 24, 2026 | 4.196M |
| July 23, 2026 | 4.045M |
| July 22, 2026 | 4.075M |
| July 21, 2026 | 4.135M |
| July 20, 2026 | 4.120M |
| July 17, 2026 | 4.226M |
| July 16, 2026 | 4.211M |
| July 15, 2026 | 4.105M |
| July 14, 2026 | 3.999M |
| July 13, 2026 | 4.271M |
| July 10, 2026 | 4.196M |
| July 09, 2026 | 4.226M |
| July 08, 2026 | 4.331M |
| July 07, 2026 | 4.392M |
| July 06, 2026 | 4.377M |
| July 02, 2026 | 4.377M |
| July 01, 2026 | 4.241M |
| June 30, 2026 | 3.864M |
| June 29, 2026 | 3.909M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.058T |
| ANI Pharmaceuticals, Inc. | 1.613B |
| Corcept Therapeutics, Inc. | 12.30B |
| Veru, Inc. | 43.99M |
| Johnson & Johnson | 648.10B |
Market Cap Related Metrics
| PEG Ratio | -0.0166 |
| Price | 6.65 |
| Earnings Yield | -248.8% |
| PEGY Ratio | -0.0166 |